GITHA SINGH | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Ms. GITHA SINGH | Pharmaceutical Science | Best Researcher Award

Regulatory Affairs Director at University of Pretoria, South Africa

Githa Singh is a distinguished pharmaceutical professional with over 24 years of expertise in regulatory affairs, quality management, and compliance. She has played a key role in medicine registration across South Africa and Africa, ensuring compliance with health authority guidelines and business regulations. Currently serving as a Regulatory Affairs Director, Githa has been instrumental in shaping pharmaceutical regulations, driving industry collaborations, and implementing strategic regulatory frameworks. She has led mergers and acquisitions, digital process transformation, business continuity planning, and crisis management while ensuring regulatory alignment across global markets. Her leadership extends to advisory roles within industry associations, where she contributes to regulatory policy development and strategic business growth. Githa’s expertise in regulatory submissions, compliance, and governance has made her a sought-after professional in the pharmaceutical sector. Her strong leadership, stakeholder engagement, and ability to streamline regulatory processes have significantly impacted the industry. She is also recognized for her ability to drive change, implement innovative regulatory solutions, and mentor professionals in the field. With an extensive background in strategic leadership and regulatory sciences, Githa continues to be a driving force in pharmaceutical compliance and regulatory policy development.

Professional Profile

Education

Githa Singh has built a strong academic foundation in pharmaceutical sciences, business administration, and pharmacology. She earned her Bachelor of Pharmacy (B.Pharm) from Rhodes University (1994-1997), equipping her with the essential knowledge of drug development, pharmaceutical formulation, and regulatory sciences. To expand her expertise globally, she completed the Foreign Pharmacists Graduate Exam (FPGEE) in 2002, administered by the National Association of Boards of Pharmacy (USA), ensuring her qualifications met international regulatory standards. Understanding the critical role of business leadership in pharmaceuticals, Githa pursued a Master of Business Administration (MBA) at the University of KwaZulu-Natal (2003-2006). This enabled her to develop skills in strategic management, operations, and pharmaceutical business development. Furthering her expertise in biostatistics and pharmacology, she completed specialized studies at the University of Pretoria in 2021. Currently, she is pursuing a Master of Science (MSc) in Pharmacology (2024) at the same institution, focusing on the scientific and regulatory aspects of drug development. Additionally, she holds industry-specific certifications, including Internationally Recognized Certified Auditor (IRCA) certification and Responsible Pharmacist accreditation. Her interdisciplinary education in pharmacy, business, and biostatistics has made her a well-rounded expert in regulatory affairs and pharmaceutical sciences.

Professional Experience

With an extensive career spanning over 24 years, Githa Singh has held key leadership roles in regulatory affairs, quality management, and compliance across multinational pharmaceutical companies. She currently serves as the Regulatory Affairs Director at AbbVie (Pty) Ltd (2012-Present), overseeing regulatory strategy and compliance across South Africa, Africa, the Middle East, and Russia. She has successfully led regulatory submissions, policy development, and digital transformation initiatives, ensuring alignment with global standards. Her role also involves business continuity planning, crisis management, and regulatory advocacy within industry associations. Previously, Githa was the Quality and Regulatory Affairs Manager at Johnson & Johnson (2011-2012), where she established Quality Management Systems, upgraded regulatory dossiers, and obtained ISO13485 certification. At Afrox (Linde Gas) (2008-2011), she managed medical device regulatory affairs and product validation processes. She also worked as a Responsible Pharmacist at Bayer Consumer Care (2003-2008), leading regulatory compliance and quality assurance initiatives. With her deep industry knowledge, she has successfully navigated complex regulatory landscapes, implemented strategic business solutions, and fostered regulatory innovation.

Research Interest

Githa Singh’s research interests lie at the intersection of regulatory sciences, pharmaceutical policy development, and innovative drug compliance strategies. She is particularly focused on streamlining regulatory approval processes, optimizing digital regulatory frameworks, and improving compliance standards in global pharmaceutical markets. Her work emphasizes regulatory harmonization across African and international markets, exploring how regulatory agencies can align policies to enhance medicine accessibility, affordability, and patient safety. She is also passionate about the role of artificial intelligence and data analytics in regulatory decision-making, advocating for evidence-based regulatory reforms. In addition, Githa’s research delves into pharmacovigilance and post-market surveillance, ensuring that pharmaceutical products maintain their safety and efficacy throughout their lifecycle. She is committed to enhancing regulatory frameworks for biologics, biosimilars, and medical devices, contributing to their efficient approval and commercialization. Her ongoing MSc research at the University of Pretoria explores advanced pharmacological principles and their regulatory implications, further solidifying her expertise in the scientific and compliance aspects of drug development. Through her research, she aims to bridge gaps between policy, innovation, and regulatory science, ensuring a progressive, efficient, and globally harmonized regulatory landscape.

Research Skills

Githa Singh possesses a diverse range of research skills that enhance her expertise in regulatory affairs, pharmaceutical sciences, and policy development. She has strong analytical and critical thinking abilities, allowing her to assess regulatory frameworks, compliance policies, and pharmacovigilance data. Her expertise in biostatistics and data interpretation enables her to apply evidence-based decision-making in regulatory submissions and quality assurance. Her skills include regulatory strategy development, where she designs optimized regulatory pathways for pharmaceutical approvals across different markets. She is proficient in pharmaceutical quality assurance and compliance auditing, ensuring adherence to ISO, WHO, and ICH guidelines. Githa is also experienced in scientific writing and regulatory documentation, including dossier preparation, clinical trial applications, and policy proposals. She has a deep understanding of risk assessment and pharmacovigilance methodologies, which she applies to monitor drug safety and post-market surveillance. Additionally, her skills extend to stakeholder engagement and negotiation, working with regulatory agencies, industry associations, and global pharmaceutical companies to shape progressive regulatory policies. Her ability to integrate business strategy with scientific research makes her a valuable leader in pharmaceutical regulatory affairs.

Awards and Honors

Githa Singh has been recognized for her exceptional contributions to regulatory affairs and pharmaceutical compliance through various awards and honors. She has been honored with the Regulatory Excellence Award for her outstanding leadership in pharmaceutical policy development and regulatory innovation. Her contributions to medicine registration and compliance strategies have earned her industry recognition from leading regulatory bodies. As a key member of industry associations, she has received accolades for her advocacy in regulatory policy reforms. Her mentorship and contributions to professional development programs have also been acknowledged through Leadership and Mentorship Awards. Githa has been invited as a keynote speaker and panelist at international regulatory conferences, highlighting her expertise in global pharmaceutical compliance, regulatory intelligence, and quality management. Her impact on digital transformation and regulatory harmonization has been widely recognized, positioning her as a thought leader in the pharmaceutical industry. Her dedication to improving regulatory frameworks and pharmaceutical governance continues to earn her recognition as an influential expert in the field.

Conclusion

Githa Singh’s illustrious career in pharmaceutical regulatory affairs showcases her unparalleled expertise in compliance, policy development, and strategic regulatory leadership. Her ability to navigate complex regulatory environments, implement innovative solutions, and drive industry-wide change has made her an influential figure in the field. Her academic and professional journey, from obtaining her pharmacy and business administration degrees to leading regulatory teams in global markets, reflects her commitment to excellence. Her research interests, technical skills, and advocacy efforts contribute significantly to advancing regulatory sciences and pharmaceutical governance. Through her leadership, mentorship, and research contributions, Githa continues to shape the future of pharmaceutical regulatory affairs, ensuring a progressive, efficient, and compliant healthcare landscape.

Publications Top Notes

  1. Title: “Transitioning to Quick Response Codes for Patient Information Leaflet Delivery”

    • Authors: Githa Singh, Sarel J. Brand, Vanessa Steenkamp

    • Journal: Exploratory Research in Clinical and Social Pharmacy

    • Volume: 17

    • Article Number: 100563

    • Year: 2025

    • DOI: 10.1016/j.rcsop.2025.100563

    • PubMed ID: 39896174

    • PMC ID: PMC11786840

  2. Title: “Assessing the Feasibility of Quick Response Codes for Patient Information Delivery in the Tshwane District”

    • Author: Githa Singh

    • Source: PQDT-Global

    • Year: 2023

Xiongfei Xu | Medicine and Dentistry | Excellence in Research

Published on by Shen Awards

Dr. Xiongfei Xu | Medicine and Dentistry | Excellence in Research

Attending Physician at Affiliated Hospital of Southwest Medical University, China

Dr. Xiongfei Xu completed his Bachelor of Medicine degree in Clinical Medicine at Luzhou Medical College in 2013. He then pursued a Master’s degree in Surgery at Southwest Medical University, graduating in 2016. His education provided him with a strong foundation in both theoretical and practical aspects of surgical and clinical medicine. Throughout his academic journey, he developed expertise in vascular biology, regenerative medicine, and translational research, which he has applied in his professional career. Although he has not undertaken postdoctoral studies, his active participation in cutting-edge research projects has contributed significantly to his scientific development. His education has equipped him with a comprehensive understanding of medical research methodologies, clinical applications, and interdisciplinary collaboration.

Professional Profile

Professional Experience

Dr. Xu began his medical career in 2016 as a physician at the Affiliated Hospital of Southwest Medical University, where he worked for over eight years, gaining extensive clinical and research experience. In December 2024, he transitioned to the Clinical Medical College of Southwest Medical University as an attending physician. His professional journey has been marked by a continuous commitment to both patient care and scientific research. His expertise in vascular medicine has enabled him to contribute to groundbreaking studies on endothelial cell function, vascular injury repair, and novel therapeutic approaches for vascular diseases. Dr. Xu’s role as an attending physician allows him to integrate clinical practice with research, ensuring that his findings have direct translational applications.

Research Interests

Dr. Xu’s research interests primarily focus on vascular biology, regenerative medicine, and translational research. His studies explore the mechanisms of vascular injury and repair, endothelial progenitor cell function, and the role of far-infrared radiation in vascular diseases. He is particularly interested in histone deacetylases (HDACs) and their impact on vascular remodeling, as well as the molecular pathways that regulate vascular calcification. His research also extends to exploring the interactions between oxidative stress, inflammatory pathways, and endothelial function in diabetic vascular complications. By investigating novel therapeutic strategies, Dr. Xu aims to contribute to the development of targeted treatments for vascular disorders, improving patient outcomes in clinical settings.

Research Skills

Dr. Xu possesses a diverse set of research skills, including experimental techniques in molecular biology, histology, and cell culture. He is proficient in conducting in vivo and in vitro studies related to vascular injury and endothelial cell function. His expertise in advanced imaging techniques, gene expression analysis, and biochemical assays has enabled him to contribute significantly to various research projects. Additionally, he has experience in clinical trial design, data analysis, and statistical modeling, which are essential for translational research. His ability to collaborate with multidisciplinary teams and integrate clinical insights with laboratory research has strengthened his contributions to vascular medicine. Furthermore, his participation in international research collaborations has enhanced his proficiency in cross-disciplinary scientific communication and project management.

Awards and Honors

Although Dr. Xu has not received formal academic awards, his research contributions have been recognized through participation in prestigious research projects. He has been a key contributor to multiple high-impact studies funded by the National Natural Science Foundation of China, the Macau Science and Technology Development Fund, and provincial health research grants. His first-author publication in Advances in Clinical and Experimental Medicine demonstrates his ability to lead scientific inquiries. His co-authorship in high-impact journals such as Nature Communications and Pharmacological Research further highlights his contributions to vascular biology research. While he has yet to receive individual research awards, his involvement in nationally and internationally funded projects reflects the scientific merit of his work.

Conclusion

Dr. Xiongfei Xu is a dedicated clinician-scientist with expertise in vascular biology and regenerative medicine. His contributions to research projects on endothelial function, vascular injury, and novel therapeutic approaches underscore his potential as a leading researcher in his field. While he has played a significant role in high-impact research, further development in leadership positions and independent research contributions would strengthen his academic profile. Expanding his first-author publications and securing individual research awards would enhance his recognition in the scientific community. His integration of clinical practice with research ensures the translational relevance of his work, making him a promising candidate for future advancements in vascular medicine.

 

Dirk Keiner | Health Professions | Innovation Excellence Award

Published on by Shen Awards

Dr. Dirk Keiner | Health Professions | Innovation Excellence Award

Pharmacist at Sophien and Hufeland Clinic Weimar, Germany

Dirk Richard Keiner is an accomplished clinical pharmacist with significant contributions to the advancement of medication safety and clinical pharmacy practice. He is the Head of the Pharmacy at the Sophien- und Hufeland-Klinikum Weimar and holds leadership roles in several professional organizations, including the ADKA Thüringen and G³ – Arbeitsgemeinschaft für moderne Medizin e.V. Keiner has also been deeply involved in education, serving as a lecturer at various institutions such as the SRH University of Health and University of Jena. His innovative research focuses on improving drug therapy management, particularly in geriatrics, oncology, and medication safety. With a vast publication record, numerous awards, and a long-standing commitment to advancing clinical pharmacy, Keiner is a recognized leader in his field.

Professional Profile

Education:

Keiner completed his pharmaceutical studies at the Ernst-Moritz-Arndt University of Greifswald, where he graduated with a degree in Pharmacy in 1996. He conducted his diploma thesis on the analysis of valerian root essential oil. Keiner further pursued a doctorate at the Humboldt University Berlin, earning a Dr. rer. nat. with magna cum laude in 2006. His doctoral research compared various instruments used to measure the quality of life in osteoporosis patients. His strong educational foundation is complemented by various advanced professional qualifications, including specialization in Clinical Pharmacy.

Professional Experience:

Keiner’s career spans multiple leadership roles in both pharmacy practice and academia. He currently serves as the Head of the Pharmacy at the Sophien- und Hufeland-Klinikum Weimar, a position he has held since 2017. Prior to this, he led the pharmacy at SRH Zentralklinikum Suhl and Waldkrankenhaus Eisenberg. His experience also includes extensive work in hospital and community pharmacies. Keiner has been actively involved in professional organizations, including serving as a board member of the ADKA Thüringen and as a delegate in the LAK Thüringen. His diverse professional background showcases his commitment to improving clinical pharmacy and patient care.

Research Interests:

Keiner’s research interests lie primarily in the area of medication safety, particularly in improving drug therapy management for older adults and cancer patients. He focuses on addressing gender-specific aspects of medication therapy and exploring the impact of drug-sun interactions. His work also extends to the development of tools for preventing medication errors and optimizing patient outcomes in clinical settings. Keiner’s research aims to bridge gaps in clinical pharmacy by tackling real-world challenges, such as the safe use of medications in vulnerable populations and the integration of new technologies into clinical practice.

Research Skills:

Keiner’s research skills are rooted in his extensive clinical pharmacy expertise, particularly in medication therapy management and safety. He is adept at conducting in-depth analyses of pharmaceutical interventions, particularly in geriatrics and oncology. Keiner employs various research methodologies, including qualitative and quantitative approaches, to assess the efficacy of drug therapy and the risks associated with certain medications. His ability to translate research findings into practical clinical applications is a hallmark of his work. Moreover, Keiner is skilled in evaluating and improving patient outcomes through the design and implementation of clinical studies that focus on medication errors and therapeutic optimization.

Awards and Honors:

Keiner’s exceptional contributions to clinical pharmacy have earned him numerous prestigious awards. Notable recognitions include the Sanofi-Synthelabo Prize for innovative work in clinical pharmacy, the Authors’ Prize from Krankenhauspharmazie, and the 1st place in the “Patient-Oriented Services” competition by the Dr. Hellmuth-Häussermann Foundation. In 2024, he received the ADKA Innovation Prize for his work on medication safety in the clinical setting. These accolades highlight his dedication to improving patient safety and advancing the field of clinical pharmacy. Keiner’s awards reflect his significant impact on both the scientific community and the practical application of pharmacy in healthcare settings.

Conclusion:

Dirk Richard Keiner’s career exemplifies innovation in clinical pharmacy, with a focus on improving medication safety and therapy management. His strong track record of leadership, research, and education, coupled with several prestigious awards, positions him as a deserving candidate for the Research for Innovation Excellence Award. While there are opportunities for expanding the global and interdisciplinary reach of his work, his contributions to the field of clinical pharmacy are significant, and his leadership in research and education make him a standout nominee.

Publication Top Notes

  1. AMTS Risk Profile Abiraterone | AMTS-Risk profile Abiraterone
    • Authors: Keiner, D.
    • Journal : M
    • Year: 2024
    • Volume: 47(3), pp. 106–114
  2. I’m Sorry, What? | Wie Bitte?
    • Authors: Keiner, D., Hoffmann, K.
    • Journal: Deutsche Apotheker Zeitung
    • Year: 2024
    • Volume: 2024(9)
  3. Probiotics & Co. – What Is Guaranteed? | Probiotics & Co. – What Is Guaranteed?
    • Authors : Keiner, D.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(12)
  4. AMTS Risk Profile Apixaban | AMTS Risk Profile Apixaban
    • Authors : Kei
    • Journal : M
    • Year: 2023
    • Volume: 46(9), pp. 319–326
  5. Check-Change-Control: Management Aspects of Arterial Hypertension in Geriatric Patients | Management Aspects of Arterial Hypertension in Geriatric Patients
    • Authors: Keiner, D., Gockel, H.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(4), pp. 114–123
  6. Risk Pyramid Allopurinol | AMTS-Risk profile Allopurinol
    • Authors: Keiner, D.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(1), pp. 12–19
  7. Much Helps Much – Or Is It? | Much Helps Much – Or Is It Not?
    • Authors: Keiner, D., Picksak, G.
    • Journal : Kr
    • Year: 2022
    • Volume: 43(9), pp. 375–376
  8. Gender-Specific Aspects of Cancer Management – ​​Ready for the Future? | Gender-Specific Aspects in Oncology Care – Ready for the Future?
    • Authors : Ke
    • Journal: Krankenhauspharmazie
    • Year: 2022
    • Volume: 43(9), pp. 353–362
  9. Gender-Specific Aspects of Drug Therapy – The New Clinical Challenge? | Gender-Specific Aspects of Drug Therapy: The New Clinical Challenge?
    • Authors: Keiner, D.
    • Journal: Krankenhauspharmazie
    • Year: 2022
    • Volume: 43(9), pp. 363–366
  10. Gender-Sensitive Medication Management | Gender-Sensitive Medication Management
    • Authors : None,
    • Journal : M
    • Year: 2022
    • Volume: 45(8), pp. 312–314

 

 

Nancy Clark | Health Professions | Women Researcher Award

Published on by Shen Awards

Assoc. Prof. Dr. Nancy Clark | Health Professions | Women Researcher Award

Nursing at University of Victoria, Canada

Dr. Nancy Clark is a dedicated scholar and researcher in the field of nursing, with a particular focus on addressing social and structural inequities in mental health care for underserved populations. She is currently an Assistant Professor at the University of Victoria, where she engages in teaching, research, and community-based initiatives aimed at promoting health equity. Dr. Clark’s research is rooted in critical theory and intersectionality, emphasizing systemic issues such as racism, classism, and sexism that contribute to social exclusion. Her work has led to meaningful contributions in public policy and healthcare service delivery. As a leader in numerous professional organizations, she collaborates with academic, community, and government partners to enhance the well-being of marginalized groups, particularly immigrants and refugees.

Professional Profile

Education

Dr. Nancy Clark holds a Ph.D. in Nursing from the University of British Columbia (2015), where her dissertation explored community capacity to support Karen refugee women’s mental health during resettlement. She also earned an M.Sc. in Nursing (2005) and a B.Sc. in Nursing (1993) from the same institution. Additionally, she holds a Diploma in Nursing from Langara College (1990). Her academic foundation combines rigorous training in nursing with a focus on mental health and social justice, enabling her to tackle complex healthcare challenges.

Professional Experience

Dr. Clark has over three decades of professional experience in nursing, academia, and community practice. Since 2017, she has served as an Assistant Professor at the University of Victoria, where she teaches and conducts research on mental health equity. Her previous roles include faculty appointments at Vancouver Community College and adjunct positions at the University of British Columbia and Simon Fraser University. Dr. Clark also has extensive experience in clinical practice, having worked in roles such as Community Mental Health Nurse, Case Manager, and Clinical Instructor in mental health and addictions. Her diverse career highlights her expertise in both theoretical and applied aspects of nursing and mental health care.

Research Interests

Dr. Clark’s research focuses on the intersection of mental health, social justice, and public policy, with an emphasis on addressing inequities affecting refugees, immigrants, and other marginalized groups. Her work explores the impact of systemic factors like racism, classism, and sexism on healthcare access and outcomes. She employs qualitative research methods, including ethnography and community-based participatory approaches, to give voice to underserved populations. Her program of research seeks to promote social justice by influencing healthcare policies and practices to recognize and address structural vulnerabilities. She is particularly interested in post-colonial and intersectionality theories, which frame her critical examination of health disparities.

Research Skills

Dr. Clark possesses advanced research skills in qualitative methodologies, including ethnographic and community-based participatory research. Her expertise extends to applying critical theoretical frameworks such as intersectionality and standpoint feminism to investigate systemic inequities in healthcare. She is adept at conducting gender-based policy analyses and translating research findings into actionable policy recommendations. Additionally, her experience in community engagement enables her to design and implement research projects that are both impactful and culturally sensitive, ensuring that marginalized populations have a voice in shaping health services and policies.

Awards and Honors

Dr. Clark’s contributions to nursing and mental health research have earned her numerous accolades and leadership roles. She is a recognized member of several prestigious organizations, including the Health Equity Collaborative Network and the Canadian Association of Schools of Nursing, where she chaired the Mental Health Nurse Educator Group. Her appointment as an Affiliate Researcher at multiple institutions, such as the UBC Centre for Migration Studies and Fraser Health Authority, underscores her influence in the field. Additionally, she has been invited to serve as a Council Member for Pathways to Prosperity Canada, highlighting her commitment to fostering inclusive communities.

Conclusion

Dr. Nancy Clark is a strong candidate for the Best Researcher Award due to her impactful contributions to addressing health inequities among marginalized populations. Her work is rooted in critical theory, social justice, and community engagement, making her research highly relevant and transformative. By expanding her dissemination efforts and emphasizing quantifiable impacts, she could further solidify her position as a leading researcher in the field.

Publication Top Notes

  • Spirituality and treatment choices by South and East Asian women with serious mental illness
    Authors: L Chiu, M Morrow, S Ganesan, N Clark
    Year: 2005
    Citations: 81
  • Pilot study and evaluation of postgraduate course on “the interface between spirituality, religion and psychiatry”
    Authors: A Grabovac, N Clark, M McKenna
    Year: 2008
    Citations: 72
  • Applying intersectionality with constructive grounded theory as an innovative research approach for studying complex populations: Demonstrating congruency
    Authors: S Kassam, L Marcellus, N Clark, J O’Mahony
    Year: 2020
    Citations: 53
  • Religion and spirituality in the context of bipolar disorder: A literature review
    Authors: B Pesut, N Clark, V Maxwell, EE Michalak
    Year: 2011
    Citations: 51
  • Immigrant women and mental health care: Findings from an environmental scan
    Authors: J O’Mahony, N Clark
    Year: 2018
    Citations: 46
  • Exploring community capacity: Karen refugee women’s mental health
    Author: N Clark
    Year: 2018
    Citations: 42
  • Applying critical race feminism and intersectionality to narrative inquiry: A point of resistance for Muslim nurses donning a hijab
    Authors: N Clark, N Saleh
    Year: 2019
    Citations: 39
  • Understanding how self-management interventions work for disadvantaged populations living with chronic conditions: Protocol for a realist synthesis
    Authors: SL Mills, J Pumarino, N Clark, S Carroll, S Dennis, S Koehn, T Yu, …
    Year: 2014
    Citations: 30
  • Exploring intersectionality as a policy tool for gender-based policy analysis: Implications for language and health literacy as key determinants of integration
    Authors: N Clark, B Vissandjée
    Year: 2019
    Citations: 15
  • Themes for evaluating the quality of initiatives to engage patients and family caregivers in decision-making in healthcare systems: A scoping review
    Authors: CB Hamilton, M Dehnadi, ME Snow, N Clark, M Lui, J McLean, …
    Year: 2021
    Citations: 12

 

 

Reihaneh Mortazavi Ardestani | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Reihaneh Mortazavi Ardestani | Medicine and Dentistry | Best Researcher Award

Author at Tehran University of Medical Sciences, Iran

Dr. Lígia O Martins is a distinguished researcher and academic specializing in the field of biomedical sciences, particularly in areas related to biomaterials, tissue engineering, and regenerative medicine. She has built a strong academic and professional career with a focus on innovation in material design, bioengineering, and translational research for medical applications. Dr. Martins is recognized for her expertise in the development of bioactive materials that promote tissue regeneration, including studies on the integration of polymers, ceramics, and other advanced biomaterials in medical applications. Throughout her career, Dr. Martins has contributed significantly to the academic and scientific communities, publishing numerous papers, receiving awards, and leading several high-impact research projects. Her work has been influential in advancing the understanding of how biomaterials can be used to address critical healthcare needs, particularly in orthopedics, wound healing, and tissue repair.

Professional Profile

Education:

Dr. Lígia O Martins holds a Ph.D. in Bioengineering, with a strong background in materials science, obtained from a prestigious institution. Her academic journey includes a Bachelor’s degree in Biology, followed by a Master’s in Biotechnology, which laid the foundation for her doctoral studies. Throughout her education, she has demonstrated exceptional scientific curiosity and dedication to advancing her understanding of biomaterials. Her educational path has not only enhanced her scientific knowledge but also fostered an interdisciplinary approach to problem-solving, combining biological sciences with engineering principles to develop novel biomaterials for medical use. The culmination of her education provided Dr. Martins with a comprehensive skill set that integrates both theoretical knowledge and practical expertise in biomedical research.

Professional Experience:

Dr. Lígia O Martins has accumulated extensive professional experience across academia, industry, and research institutions. She has held key academic positions in renowned universities, contributing as a faculty member and principal investigator in multiple research projects. Her professional journey also includes collaborations with industry leaders in the fields of biomaterials, biotechnology, and medical devices, where she has applied her research in practical settings. Dr. Martins has served as a mentor to graduate and postdoctoral students, fostering the next generation of scientists in the field of biomedical engineering. She has also contributed to various international research consortiums and has been involved in the management of large-scale research projects aimed at solving real-world medical challenges, particularly those related to tissue regeneration and biomaterial development.

Research Interests:

Dr. Lígia O Martins’ research interests lie at the intersection of biomaterials, tissue engineering, and regenerative medicine. She is particularly focused on the design and development of bioactive materials that can enhance tissue regeneration and repair. Her work involves the creation of novel biomaterial scaffolds for use in bone, cartilage, and soft tissue regeneration, as well as the incorporation of growth factors and other bioactive molecules to improve healing outcomes. Dr. Martins is also interested in the design of materials that are biocompatible and capable of interacting favorably with biological tissues to promote the regeneration of damaged or diseased tissues. Her research spans areas such as the development of injectable hydrogels, 3D-printed scaffolds, and hybrid materials that combine polymers and ceramics for medical applications.

Research Skills:

Dr. Lígia O Martins possesses a diverse skill set in both experimental and computational research. She is proficient in the design and synthesis of novel biomaterials, with a strong emphasis on polymer chemistry, material characterization, and mechanical testing. Her research skills also extend to cell culture techniques, including the analysis of cell-material interactions, tissue regeneration assays, and the assessment of material biocompatibility. In addition, Dr. Martins has significant experience with advanced imaging techniques, such as scanning electron microscopy (SEM) and confocal microscopy, for analyzing material structures and biological responses. She is skilled in the use of various analytical tools for evaluating the properties of materials, such as mechanical testing, biodegradability studies, and in vitro biological assays. Her multidisciplinary approach combines engineering principles with biological insights, making her highly skilled in conducting research at the interface of material science and biology.

Awards and Honors:

Throughout her career, Dr. Lígia O Martins has received numerous awards and honors recognizing her contributions to the field of biomedical research. She has been acknowledged for her excellence in research and her ability to translate scientific discoveries into practical applications. Dr. Martins has received prestigious fellowships and research grants that have enabled her to lead innovative projects on biomaterials and regenerative medicine. She has also been the recipient of awards for her exceptional publications in top-tier scientific journals, which have been cited extensively in the field. In addition, Dr. Martins has been invited to present her research at various international conferences, further solidifying her reputation as a leader in the biomaterials and tissue engineering fields. These accolades highlight her outstanding impact on the scientific community and her commitment to advancing healthcare through innovative research.

Conclusion:

Reihaneh Mortazavi Ardestani is a highly capable and promising researcher in the field of radiology, with significant accomplishments in clinical practice, teaching, and innovative research. Her dedication to advancing medical imaging, particularly through AI applications, positions her as an excellent candidate for the Best Researcher Award. Further development in leadership roles and international collaborations would enhance her already impressive career trajectory.

Umama Umar | Health Professions | Best Researcher Award

Published on by Shen Awards

Dr. Umama Umar | Health Professions | Best Researcher Award

Physiotherapist at Faisal institute of health sciences faisalabad, Pakistan

Dr. Umama Umar is an experienced physiotherapist accredited by London, UK, with a strong background in physical therapy and clinical practice. She holds a Doctor of Physical Therapy degree from Government College University Faisalabad and has completed a postgraduate BCTP course from the International School of Rehabilitation Sciences. Her research focuses on improving postoperative outcomes and prehabilitation, with publications in international journals and registered clinical trials. Dr. Umar’s practical experience includes roles at Saad Medical Complex and various hospitals, and she is actively involved in content writing and online platforms related to physiotherapy. Additionally, she has certifications in disaster response and specialized physiotherapy skills. As the Regional Head of the Health Physio Association, she demonstrates leadership and a commitment to mentoring. Her diverse skill set, combined with her research and clinical experience, highlights her dedication to advancing physiotherapy practices.

Profile

Education

Dr. Umama Umar’s educational background reflects a robust foundation in physiotherapy and related fields. She graduated with a Doctor of Physical Therapy degree from Government College University Faisalabad (FIHS) in August 2022, where she developed a comprehensive understanding of physical therapy principles and practices. Additionally, Dr. Umar completed a Postgraduate BCTP course from the International School of Rehabilitation Sciences, an institution accredited by London, UK, further enhancing her expertise in advanced physiotherapy techniques. Her educational journey also includes a Diploma in Unani Medicine and Surgery (DUMS) from Pakistan Tibbia College, which provides a unique perspective on integrative medicine. This diverse educational background equips Dr. Umar with a well-rounded skill set, combining traditional and modern therapeutic approaches, and underpins her research and clinical practice in the field of physiotherapy.

Professional Experience

Dr. Umama Umar, a dedicated physiotherapist accredited by London, UK, has garnered extensive professional experience in her field. From February 2022 to March 2024, she worked at Saad Medical Complex in Faisalabad, Pakistan, where she applied her expertise in patient care and rehabilitation. Concurrently, she has been an Independent Female Physiotherapist and content writer for Seek Physio Platform since January 2021, contributing valuable insights through her articles. Her clinical experience also includes internships at Faisal Hospital and Khatija Memorial Trust Hospital in Faisalabad. Dr. Umar’s practical experience is complemented by her role as a Regional Head of the Health Physio Association (HPA), where she has demonstrated strong leadership and mentoring abilities. Her broad experience not only enhances her clinical practice but also enriches her contributions to research and education in physiotherapy.

Research Interest

Dr. Umama Umar’s research interests primarily revolve around improving postoperative outcomes through innovative physiotherapy techniques and prehabilitation strategies. Her work extensively explores the effects of respiratory muscle training and prehabilitation resistance exercises on postoperative health-related quality of life in patients undergoing major surgeries, such as mitral valve replacement and coronary artery bypass grafting. Dr. Umar is particularly focused on how these interventions can enhance recovery and overall health in clinically frail patients. Her research aims to bridge the gap between clinical practice and evidence-based physiotherapy, contributing valuable insights into optimizing patient outcomes. Additionally, her involvement in community action for disaster response and her expertise in manual therapy techniques further enrich her research perspective. By integrating these elements, Dr. Umar seeks to advance the field of physiotherapy, improve patient care, and influence best practices in both clinical and research settings.

Research Skills

Dr. Umama Umar demonstrates a robust set of research skills that underpin her contributions to the field of physiotherapy. Her research expertise is evident from her published work, including studies on respiratory muscle training and prehabilitation techniques aimed at improving postoperative outcomes. Dr. Umar’s proficiency in conducting clinical trials, as shown by her research registered in the Iranian Registry of Clinical Trials, highlights her ability to design and execute rigorous studies. She excels in data analysis and technical writing, skills essential for producing high-quality research papers and posters. Additionally, her experience with manual therapy and myofascial release techniques enriches her research with practical insights. Her educational background, including a Doctor of Physical Therapy and postgraduate coursework, supports her solid theoretical foundation. Overall, Dr. Umar’s research skills are characterized by a blend of practical experience, technical proficiency, and a commitment to advancing the field through rigorous scientific inquiry.

Award and Recognition

Dr. Umama Umar has garnered notable recognition in the field of physiotherapy through her significant contributions and dedication. Her impactful research on respiratory muscle training and prehabilitation, published in high-quality international journals, highlights her commitment to advancing postoperative care. Dr. Umar’s practical experience as a physiotherapist at Saad Medical Complex and various clinical settings has enriched her research and teaching capabilities. Her role as Regional Head of the Health Physio Association underscores her leadership and influence within the profession. Additionally, her certifications in community disaster response and advanced physiotherapy techniques reflect her commitment to ongoing professional development. Despite these achievements, further recognition through higher-impact publications and successful research funding could enhance her profile. Dr. Umar’s blend of research excellence, practical experience, and leadership makes her a distinguished figure in her field, deserving of further awards and accolades.

Conclusion

Dr. Umama Umar is a promising candidate for the Research for Best Researcher Award due to her substantial contributions to physiotherapy research, practical experience, and leadership in the field. To strengthen her candidacy, focusing on expanding her publication impact, exploring diverse research areas, gaining experience in research funding, and enhancing collaborative efforts would be beneficial. Her dedication to advancing physiotherapy practices and education positions her well for recognition in this award category.

Publications Top Notes

  1. Effects of Preoperative Respiratory Muscle Training for Improvement of Postoperative Health-Related Quality of Life in Mitral Valve Replacement Patients
    • Authors: Umama Umar; Ahad Hussain; Komal Tariq
    • Year: 2024
    • Journal: Physiotherapy Research International
    • DOI: 10.1002/pri.2123
  2. Comparison of Respiratory Prehabilitation for Improvement of Postsurgery Outcomes in Mitral Valve Patients
    • Authors: Dr. Umama Umar; Ahad Hussain; Komal Tariq; Ramesha Tahir; Munaza Tabassum
    • Year: 2024
    • Conference Poster: ScienceOpen Posters
    • DOI: 10.14293/P2199-8442.1.SOP-.PHVJ2K.v1

 

Olufemi Matson Badmus | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Olufemi Matson Badmus | Medicine and Dentistry | Best Researcher Award

Fellow West Africa College of Surgeon at Federal Medical Centre Abeokuta, Nigeria

Dr. Olufemi Matson Badmus is an accomplished Obstetrician and Gynaecologist based at Royal Preston Hospital, UK. With extensive clinical experience gained through his roles in Nigeria and the UK, Dr. Badmus has excelled in managing complex obstetric and gynaecological cases and teaching medical professionals. His notable achievements include significant audits that improved patient care, such as enhancing postmenopausal bleeding services, and his contributions to research, including studies on ovarian cancer and umbilical cord blood lactate. He is a dedicated educator, actively involved in teaching medical students and junior doctors and contributing to key medical handbooks and guidelines. Dr. Badmus’s additional qualifications in Global Health from the University of Washington further complement his expertise. His leadership in clinical governance, combined with his commitment to improving patient outcomes and advancing medical education, underscores his suitability for the Research for Best Researcher Award.

Profile

Education

Dr. Olufemi Matson Badmus earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) in 2009, laying the foundation for his medical career. He furthered his expertise by becoming a Fellow of the West African College of Surgeons (FWACS) in 2021, specializing in Obstetrics and Gynaecology. Dr. Badmus expanded his knowledge in global health through additional qualifications, completing courses in Leadership in Global Health and Economic Evaluation of Global Health at the University of Washington in 2019. His education reflects a commitment to both clinical excellence and a broader understanding of healthcare systems and management. This comprehensive educational background has equipped him with a robust skill set, enabling him to contribute effectively to his field through both clinical practice and research.

Professional Experience

Dr. Olufemi Matson Badmus brings extensive professional experience in Obstetrics and Gynaecology. Since March 2021, he has served as a Senior Clinical Fellow at Royal Preston Hospital, Lancashire Teaching Hospital NHS Trust, where he manages the labour ward, oversees obstetric emergencies, and performs complex procedures with remote supervision. Prior to this, Dr. Badmus was a Senior Registrar at Federal Medical Centre, Abeokuta, Nigeria, from 2016 to 2021, and a Junior Registrar there from 2013 to 2016. His career began as a Medical Officer during his National Youth Service Corps in Nigeria. His clinical expertise is complemented by a solid background in teaching, including facilitating obstetric simulation and training medical students. Dr. Badmus has also contributed to clinical audits, quality improvement projects, and has been involved in research and publication, enhancing patient care and advancing clinical practices.

Research Interest

Dr. Olufemi Matson Badmus’s research interests are primarily centered on improving clinical outcomes and patient safety within Obstetrics and Gynaecology. His research focuses on critical aspects such as the evaluation of intrapartum asphyxia through umbilical arterial cord blood lactate levels and the management of obstetric emergencies. Dr. Badmus has also contributed to significant studies like the IMPRESS study on ovarian cancer and has developed clinical audits and quality improvement projects to enhance patient care in postmenopausal bleeding and other gynaecological services. His work integrates clinical practice with research to drive improvements in care protocols and patient satisfaction. Additionally, his involvement in global health and economic evaluation courses reflects a broader interest in how health systems can be optimized for better outcomes. Dr. Badmus’s research aims to bridge gaps in clinical knowledge and contribute to evidence-based practices in obstetrics and gynaecology.

Research Skills

Dr. Olufemi Matson Badmus possesses a diverse and impactful set of research skills. His expertise includes conducting clinical audits and Quality Improvement Projects (QIPs) aimed at enhancing patient care in Obstetrics and Gynaecology. Notably, he has led audits that significantly improved postmenopausal bleeding services and developed new standard operating procedures, demonstrating his ability to translate research findings into practical improvements. His research contributions extend to high-profile studies such as the IMPRESS study on ovarian cancer and investigations into the role of umbilical cord blood lactate in predicting neonatal outcomes. Dr. Badmus has also contributed to important publications like the Medical Trainees Initiative handbook and the StratOG module on Safe Abortion Care. His skills in clinical research are complemented by his involvement in multidisciplinary teams and teaching, highlighting his ability to integrate research with practical application and education in his field.

Award and Recognition

Dr. Olufemi Matson Badmus has earned notable accolades and recognition for his exceptional contributions to Obstetrics and Gynaecology. His extensive clinical expertise and innovative work have been acknowledged through various awards and honors. Dr. Badmus’s leadership and clinical excellence were underscored by his fellowship with the West African College of Surgeons and his impactful role in the NHS. He has received commendations for his significant improvements in patient care, including the successful audit outcomes and the enhancement of postmenopausal bleeding services. His dedication to education is reflected in his role as a faculty member for PROMPT and contributions to important medical handbooks and research studies. Additionally, his presentations at prestigious conferences, such as the RCOG Congress and British Gynaecology Cancer Society, highlight his commitment to advancing the field. These achievements collectively underscore Dr. Badmus’s standing as a distinguished and respected figure in his field.

Conclusion

Dr. Olufemi Matson Badmus is a strong candidate for the Research for Best Researcher Award due to his extensive clinical experience, significant contributions to patient care, and active involvement in teaching and research. His strengths lie in his impactful work in improving patient outcomes, his leadership roles, and his dedication to education. Addressing the areas for improvement, such as expanding research impact and increasing international visibility, could further elevate his candidacy. Overall, his profile reflects a well-rounded and accomplished researcher whose work has made meaningful contributions to the field of Obstetrics and Gynaecology.

Publications Top Notes

Umbilical Arterial Blood Lactate as Predictor of Early Neonatal Outcome and Evaluation of Intrapartum Asphyxia

  • Journal: Journal of Taibah University Medical Sciences
  • Year: 2024
  • Month: September
  • DOI: 10.1016/j.jtumed.2024.08.027
  • Authors: Olufemi M. Badmus, Olaide R. Adenaya, Oluseyi A. Aderinwale, Bernard O. Ewuoso, Babatunde S. Awolaja, Adedoyin O. Ade-Onojobi

 

Marine Gogia | Medicine | Best Researcher Award

Published on by Shen Awards

Dr. Marine Gogia | Medicine | Best Researcher Award

Program Director at Georgian Harm Reduction Network, Georgia.

Dr. Marine Gogia is a distinguished Public Health Specialist and Patient Advocate with extensive experience in harm reduction and epidemiology. She is currently pursuing a Ph.D. in Public Health and Epidemiology at Tbilisi State University and SUNY Albany, following her Master’s in Public Health from the University of Georgia. Dr. Gogia’s career highlights include her role as Programs Director at the Georgian Harm Reduction Network, where she manages significant projects like the Global Fund initiative targeting HIV/AIDS prevention and harm reduction. Her research encompasses HIV self-testing, hepatitis C treatment, and risk behavior assessments among marginalized groups. Dr. Gogia’s contributions extend to her leadership roles with the European AIDS Treatment Group and various international health organizations. She has been recognized for her impactful research and advocacy, which include numerous publications and presentations at global conferences.

Profile
Education

Dr. Marine Gogia is a highly educated public health specialist with a strong academic background. She is currently pursuing a Ph.D. in Public Health and Epidemiology at Tbilisi State University and SUNY Albany, USA (2022-2025). She holds a Master’s Degree in Public Health (MPH) from the University of Georgia, which she completed between 2006 and 2009. Dr. Gogia’s foundational education was at Tbilisi State Medical University, where she studied Preventive Medicine (1996-2002). Her commitment to continuing education is evident from her participation in specialized courses, including the European Patients Academy (EUPATI) Expert Patients Course (2017-2018) and the EATG Training Academy’s STEP-UP program (2014-2015). This extensive educational background has equipped her with a robust understanding of public health, epidemiology, and the skills necessary to address complex health challenges effectively.

Professional Experience

Dr. Marine Gogia, a distinguished Public Health Specialist and Patient Advocate, has amassed extensive experience in public health, harm reduction, and infectious disease control. Currently a Programs Director at the Georgian Harm Reduction Network (GHRN), she leads critical projects such as the Global Fund initiative to prevent HIV/AIDS and minimize drug-related harm. Her role encompasses both management and research, with notable studies on HIV self-testing and Hepatitis C elimination. Dr. Gogia has also contributed as a Co-chair at the European AIDS Treatment Group (EATG), where she provides technical expertise and strategic direction. Her prior roles include consulting for WHO and the Global Fund, and serving as a Program Coordinator at Curatio International Foundation. Her work reflects a commitment to improving health outcomes and advocating for marginalized communities through rigorous research and strategic program implementation.

Research Interest

Dr. Marine Gogia’s research interests center around public health, with a particular focus on HIV/AIDS, harm reduction, and epidemiology. She is dedicated to advancing strategies for combating HIV and hepatitis C, especially among vulnerable populations such as people who inject drugs (PWID) and marginalized groups. Her work involves evaluating and improving harm reduction programs, assessing risky behaviors, and enhancing access to healthcare services through innovative research methodologies like simplified bio-behavioral surveillance surveys. Dr. Gogia is also actively involved in policy advocacy and capacity building, contributing to global health guidelines and strategies. Her research aims to bridge gaps in healthcare access and improve the effectiveness of public health interventions, with significant contributions to regional and international efforts in infectious disease control and prevention.

Research Skills

Dr. Marine Gogia possesses exceptional research skills demonstrated through her extensive experience in public health and epidemiology. Her expertise includes conducting bio-behavioral surveillance surveys, operational research, and evaluating HIV and hepatitis C testing and treatment programs. Dr. Gogia excels in designing and implementing research methodologies, such as the BSS-Lite survey, to assess risky behaviors among people who inject drugs (PWIDs). She is adept at analyzing data related to HIV self-testing acceptability and identifying barriers to HCV program enrollment. Her research skills are further evident in her contributions to studies on legal and regulatory barriers, and her ability to synthesize complex information into actionable insights for policy-making. Dr. Gogia’s proficiency extends to training and consultancy, where she effectively translates research findings into practical solutions for public health challenges. Her work consistently reflects a high level of analytical rigor and a commitment to advancing public health outcomes.

Awards and Recognition

Maryam has received several certificates of participation and training, including the Training of Trainers certificates, a peer reviewer course, and various certificates in statistical analysis and genetic research. These accolades demonstrate her commitment to continuous learning and professional development.

Conclusion

Maryam Qasim is a promising candidate for the Best Researcher Award due to her significant contributions to antimicrobial resistance research and molecular genetics. Her work, although primarily regional, has the potential to address broader health issues through applied research and collaborative efforts. Her academic background and continued professional development through various certifications further strengthen her candidacy.

Publications Top Notes

  1. Progress Toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015-April 2024
    • Authors: Tohme, R.A., Shadaker, S., Adamia, E., Schumacher, I.T., Gabunia, T.
    • Year: 2024
  2. Piloting a Simplified Bio-Behavioural Survey Methodology, the BBS-Lite, Among People Who Inject Drugs in Georgia
    • Authors: Gogia, M., Ruadze, E., Kasrashvili, T., Khonelidze, I., Stvilia, K.
    • Year: 2024
  3. Recommendations for Defining Preventable HIV-Related Mortality for Public Health Monitoring in the Era of Getting to Zero: An Expert Consensus
    • Authors: Croxford, S.E., Martin, V., Lucas, S.B., Waters, L.J., Sullivan, A.K.
    • Year: 2023
    • Citations: 1
  4. Barriers of Linkage to HCV Viremia Testing Among People Who Inject Drugs in Georgia
    • Authors: Butsashvili, M., Abzianidze, T., Kamkamidze, G., Nasrullah, M., Averhoff, F.
    • Year: 2022
    • Citations: 2
  5. Hidden Populations: Risk Behaviours in Drug-Using Populations in the Republic of Georgia Through Subsequent Peer-Driven Interventions
    • Authors: Lawlor, C., Gogia, M., Kirtadze, I., Jikia, G., Zurashvili, T.
    • Year: 2021
    • Citations: 1
  6. A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic
    • Authors: Farhoudian, A., Radfar, S.R., Ardabili, H.M., Yitayih, Y., Zhao, M.
    • Year: 2021
    • Citations: 44
  7. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey
    • Authors: Radfar, S.R., De Jong, C.A.J., Farhoudian, A., Zhao, M., Zonoozi, A.K.
    • Year: 2021
    • Citations: 53
  8. Integration of Hepatitis C Treatment at Harm Reduction Centers in Georgia—Findings from a Patient Satisfaction Survey
    • Authors: Butsashvili, M., Kamkamidze, G., Kajaia, M., Japaridze, M., Averhoff, F.
    • Year: 2020
    • Citations: 9
  9. Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs — Georgia, 2018
    • Authors: Stvilia, K., Spradling, P.R., Asatiani, A., Averhoff, F., Nasrullah, M.
    • Year: 2019
    • Citations: 17
  10. Hidden Populations: Discovering the Differences Between the Known and the Unknown Drug-Using Populations in the Republic of Georgia
    • Authors: Gogia, M., Lawlor, C., Shengelia, N., Stvilia, K., Raymond, H.F.
    • Year: 2019
    • Citations: 1

 

Farzad Shidfar | Health Professions | Best Researcher Award

Published on by Shen Awards

Prof. Farzad Shidfar | Health Professions | Best Researcher Award

Faculty Member at Iran University of Medical Sciences, Iran

Professor Farzad Shidfar is a distinguished academic in the field of nutrition, currently serving at the Iran University of Medical Sciences. With a robust educational background, including a Ph.D. in Nutrition from Tehran University of Medical Sciences, he has made significant contributions to the field through his research. His work spans a range of topics including dietary impacts on chronic diseases, the effects of various supplements, and the management of irritable bowel syndrome and cardiovascular risk factors. Professor Shidfar has published extensively, with recent studies focusing on the impact of FODMAP diets, ellagic acid supplementation, and the role of probiotics. His research has been influential in understanding nutritional interventions and their effects on health outcomes. His extensive publication record and contributions to clinical trials reflect his commitment to advancing nutritional science and improving public health.

Professional Profile

Education

Professor Farzad Shidfar’s educational background reflects a strong foundation in nutrition and health sciences. He earned his Bachelor’s degree in Nutrition from Isfahan University of Medical Sciences, Isfahan, Iran, in 1993. Building on this, he pursued a Master’s degree in Nutrition at Tabriz University of Medical Sciences, Tabriz, Iran, which he completed in 1996. His academic journey culminated with a Ph.D. in Nutrition from Tehran University of Medical Sciences, Tehran, Iran, in 2002. Professor Shidfar’s extensive educational training equips him with a deep understanding of nutritional science, allowing him to contribute significantly to research and academic discourse in the field. His advanced degree in English further complements his scholarly activities, enabling effective communication and collaboration within the global scientific community.

Professional Experience

Professor Farzad Shidfar is a distinguished academic in the field of nutrition, currently serving at the Department of Nutrition, School of Health, Iran University of Medical Sciences. He earned his Bachelor’s degree in Nutrition from Isfahan University of Medical Sciences in 1993, a Master’s in Nutrition from Tabriz University of Medical Sciences in 1996, and a Ph.D. in Nutrition from Tehran University of Medical Sciences in 2002. His extensive career includes significant contributions to the study of dietary impacts on health, with a focus on managing conditions such as irritable bowel syndrome, ulcerative colitis, and cardiovascular diseases. Professor Shidfar has led numerous clinical trials and systematic reviews, addressing various aspects of nutrition and its effects on health. His work is widely published in peer-reviewed journals, demonstrating his expertise and commitment to advancing knowledge in the field of nutrition.

Research Interest

Professor Farzad Shidfar’s research interests lie predominantly in nutrition and its impact on various health conditions. His work focuses on dietary interventions and their effects on chronic diseases such as irritable bowel syndrome, multiple sclerosis, and ulcerative colitis. He explores the influence of specific nutrients and dietary patterns on inflammation, oxidative stress, and neuroprotection. His research extends to examining the role of supplements like ellagic acid, berberine, and selenium in managing disease activity and improving patient outcomes. Professor Shidfar is also deeply involved in evaluating the efficacy of dietary strategies for cardiovascular risk reduction and the modulation of metabolic syndrome. His extensive publications reflect his commitment to advancing our understanding of nutritional science and its practical applications in health and disease management.

Research Skills

Professor Farzad Shidfar possesses a broad and deep skill set in nutrition research, underscoring his significant contributions to the field. His expertise includes systematic reviews and meta-analyses, as evidenced by his comprehensive evaluations of dietary impacts on health conditions such as irritable bowel syndrome, multiple sclerosis, and cardiovascular risk factors. Professor Shidfar is adept at conducting randomized controlled trials, as demonstrated in his studies on the effects of dietary supplements and functional foods on various health outcomes. His proficiency in statistical analysis and data interpretation enables him to draw meaningful conclusions from complex datasets, supporting evidence-based dietary recommendations. Additionally, his experience extends to interdisciplinary research, collaborating with experts across fields to address global health issues. Professor Shidfar’s ability to integrate applied research with practical applications highlights his commitment to advancing nutritional science and improving public health outcomes.

Awards and Recognition

Professor Shidfar’s achievements in research have been recognized through various awards and honors. His publications in high-impact journals and his contributions to multiple clinical trials and systematic reviews attest to his standing in the scientific community. His work not only advances the field of nutrition but also impacts public health policies and practices.

Conclusion

In conclusion, Professor Farzad Shidfar is a highly accomplished researcher with significant contributions to nutrition and health sciences. His extensive research, collaborative efforts, and applied focus make him a strong candidate for the Research for Women Researcher Award. His work addresses critical health issues, spans a wide geographic impact, and intersects with broader environmental and public health concerns.

Publications Top Notes

  • Ultra-Processed food intake and risk of Helicobacter pylori infection: A case–control study
    • Authors: Z. Ebrahimi, Z. Shateri, M. Nouri, F. Shidfar, M. Hejazi
    • Journal: Food Science and Nutrition
    • Volume: 12(7)
    • Pages: 5019–5026
    • Year: 2024
  • Effects of a low FODMAP diet on the symptom management of patients with irritable bowel syndrome: a systematic umbrella review with the meta-analysis of clinical trials
    • Authors: M. Khalighi Sikaroudi, S. Soltani, S.M. Ghoreishy, F. Shidfar, A. Dehnad
    • Journal: Food and Function
    • Volume: 15(10)
    • Pages: 5195–5208
    • Year: 2024
  • Assessment of the anti-inflammatory and anti-glycemic properties of Royal Jelly and Tocotrienol-rich fraction in an experimental study: Does irisin mediate these effects?
    • Authors: N. Mesri Alamdari, P. Irandoost, N. Roshanravan, H. AmirAzad, F. Shidfar
    • Journal: Food Science and Nutrition
    • Year: 2024
  • The effects of Ellagic acid supplementation on neurotrophic, inflammation, and oxidative stress factors, and indoleamine 2, 3-dioxygenase gene expression in multiple sclerosis patients with mild to moderate depressive symptoms: A randomized, triple-blind, placebo-controlled trial
    • Authors: G. Hajiluian, S.J. Karegar, F. Shidfar, J. Heshmati, A.-A. Delbandi
    • Journal: Phytomedicine
    • Volume: 121
    • Article: 155094
    • Year: 2023
    • Citations: 7
  • The effects of synbiotics supplementation on reducing chemotherapy-induced side effects in women with breast cancer: a randomized placebo-controlled double-blind clinical trial
    • Authors: Y. Khazaei, A. Basi, M.L. Fernandez, R. Bagherzadeh, F. Shidfar
    • Journal: BMC Complementary Medicine and Therapies
    • Volume: 23(1)
    • Article: 339
    • Year: 2023
    • Citations: 6
  • Effects of berberine and barberry on selected inflammatory biomarkers in adults: A systematic review and dose–response meta-analysis of randomized clinical trials
    • Authors: Y. Vahedi-Mazdabadi, H. Shahinfar, M. Toushih, F. Shidfar
    • Journal: Phytotherapy Research
    • Volume: 37(12)
    • Pages: 5541–5557
    • Year: 2023
    • Citations: 5
  • The effect of selenium supplementation on disease activity and immune-inflammatory biomarkers in patients with mild-to-moderate ulcerative colitis: a randomized, double-blind, placebo-controlled clinical trial
    • Authors: M. Khazdouz, N.E. Daryani, M. Cheraghpour, S.B. Ghavami, F. Shidfar
    • Journal: European Journal of Nutrition
    • Volume: 62(8)
    • Pages: 3125–3134
    • Year: 2023
    • Citations: 3
  • Comparison of predictive effect of the dietary inflammatory index and empirically derived food-based dietary inflammatory index on the menopause-specific quality of life and its complications
    • Authors: N. Haghshenas, F.H. Baharanchi, E. Melekoglu, M.H. Sohouli, F. Shidfar
    • Journal: BMC Women’s Health
    • Volume: 23(1)
    • Article: 349
    • Year: 2023
    • Citations: 1
  • The effects of melissa officinalis on depression and anxiety in type 2 diabetes patients with depression: a randomized double-blinded placebo-controlled clinical trial
    • Authors: M. Safari, A. Asadi, N. Aryaeian, A.F. Hosseini, Z. Hamidi
    • Journal: BMC Complementary Medicine and Therapies
    • Volume: 23(1)
    • Article: 140
    • Year: 2023
    • Citations: 8
  • The effects of aqueous and ethanolic extracts of Rheum ribes on insulin-resistance and apolipoproteins in patients with type 2 diabetes mellitus: a randomized controlled trial
    • Authors: A. Ghafouri, S. Jafari Karegar, G. Hajiluian, I. Heydari, F. Shidfar
    • Journal: BMC Complementary Medicine and Therapies
    • Volume: 23(1)
    • Article: 46
    • Year: 2023
    • Citations: 2